Amgen and Adaptive Biotechnologies to develop a therapeutic to prevent or treat COVID-19
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
COVID-19 | Diagnostics | FDA
FDA approved Emergency IND Use of Humanigen’s lenzilumab for compassionate use in COVID-19 patients
On Apr. 2, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to the U.S….
Vanda Pharma announced initiation of FDA approved clinical study of Tradipitant patients with severe COVID-19 pneumonia
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
Biotechnology | COVID-19 | FDA | Therapeutics
Incyte initiated phase 3 clinical trial of Ruxolitinib (Jakafi) as treatment for patients with COVID-19 cytokine storm
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
COVID-19 | Therapeutics | WHO
CHF Solutions doubled production staff of Aquadex SmartFlow consoles due to hospital demand
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
BioAegis accelerated multiple clinical trial submissions for severe COVID-19 pneumonia patients
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
Collaborative effort brings new COVID-19 treatment approach to Western New York
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
GW Hospital used VR technology to see into COVID-19 patientﾒs lungs
On Apr. 2, 2020, George Washington University Hospital announed it had used Virtual Reality technology to see into…
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
UW-Madison, FluGen and Bharat Biotech announced development of CoroFlu, a coronavirus vaccine
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies…
Philips enabled hospitals and GPs to remotely screen and monitor patients with COVID-19
On Apr. 1, 2020, Philips announced that it can help general practitioners and healthcare institutions manage the increased…
ImmunityBio combined supercomputing power with Microsoft Azure to target infection -Doorway of the Coronavirus
On Apr. 1, 2020, ImmunityBio, a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it…
Innovation Pharma received data supporting Brilacidinﾒs direct inhibition of SARS-CoV-2
On Apr. 1, 2020, Innovation Pharma it had received data supporting Brilacidinﾒs direct inhibition of SARS-CoV-2, the novel…
Paratek Pharma announced BARDA funding for onshoring the manufacturing supply for NUZYRA (omadacycline)
On Apr. 1, 2020, Innovation Pharma announced BARDA had initiated funding to support the onshoring of Paratek manufacturing…
Cantel announced iInitiatives to help fight COVID-19
On Apr. 1, 2020, Cantel Medical announced it has accelerated surgical earloop mask production by its HuFriedyGroup dental…
Henry Schein named exclusive distributor of second point-of-care antibody rapid test
On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S….
Diffusion Pharma announced evaluating TSC against Acute Respiratory Distress Syndrome in COVID-19 patients
On Apr. 1, 2020, Diffusion Pharmaceuticals announced it had begun a cooperative research effort with University of Virginia…
Early study of COVID-19 patients showed high mortality rate
On Apr. 1, 2020, a University of Washington Medicine led study of 24 of the most critically ill…
Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerated delivery
On Mar. 31, 2020, Philips announced that it was fully committed to fulfill the contract with the U.S….
Vaxart provided update on its oral COVID-19 vaccine program
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
Sorrento announced research testing agreement with University of Texas for preclinical testing of COVID-19 therapeutic product candidates
On Mar. 31, 2020, Sorrento announced it had entered into a research testing agreement with The University of…
Kleo Pharmaceuticals announced research collaboration with Green Cross LabCell to develop COVID-19-targeting allogeneic NK Cell combination therapy
On Mar. 31, 2020, Kleo Pharmaceuticals announced it had entered into a research collaboration with South Korea -based…
Mayo Clinic in Florida expanded specimen testing and processing capabilities for COVID-19
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
BD, BioMedomics announced launch of rapid serology test to detect exposure to COVID-19
On Mar. 31, 2020, BD (Becton, Dickinson and Company) and BioMedomics announced the release of a new point-of-care…
Chembio announced launch of DPP COVID-19 serological point-of-care test
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
Luminex received BARDA contract to support development of second, rapid SARS-CoV-2 test
On Mar. 31, 2020, Luminex announced it had received $642,450 in funding from the Biomedical Advanced Research and…
VBI Vaccines announced collaboration with National Research Council of Canada to develop pan-Coronavirus vaccine candidate
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…